Updated May 15, 2018 This content is archived.
New Jacobs School of Medicine and Biomedical Sciences research has shown that an approved anti-cancer drug can significantly restore the social deficits associated with autism spectrum disorder in mice. “We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, SUNY Distinguished Professor of physiology and biophysics.
No events scheduled.